Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- Creator: Davies, Christina , Pan, Hongchao , Bradbury, Joan , Clarke, Michael , Collins, Rory , Davis, Susan R. , Delmestri, Antonella , Forbes, John F. , Haddad, Peiman , Hou, Ming-Feng , Inbar, Moshe , Khaled, Hussein , Godwin, Jon , Kielanowska, Joanna , Kwan, Wing-Hong , Mathew, Beela S. , Mittra, Indraneel , Mueller, Bettina , Nicolucci, Antonio , Peralta, Octavio , Pernas, Fany , Petruzelka, Lubos , Pienkowski, Tadeusz , Gray, Richard , Radhika, Ramachandran , Rajan, Balakrishnan , Rubach, Maryan T. , Tort, Sera , Urrutia, Gerard , Valentini, Miriam , Wang, Yaochen , Peto, Richard , Arriagada, Rodrigo , Raina, Vinod , Abraham, Mirta , Medeiros Alencar, Victor Hugo , Badran, Atef , Bonfill, Xavier
- Resource Type: journal article
- Date: 2013
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 Study
- Creator: Colleoni, Marco , Giobbie-Hurder, Anita , Chirgwin, Jacquie , Pienkowski, Tadeusz , Wardley, Andrew , Price, Karen N. , Gelber, Richard D. , Coates, Alan S. , Goldhirsch, Aron , Regan, Meredith M. , Thürlimann, Beat , Mouridsen, Henning , Mauriac, Louis , Forbes, John F. , Paridaens, Robert , Láng, István , Smith, Ian
- Resource Type: journal article
- Date: 2011